Lilly to Acquire Adverum Biotechnologies
October 24, 2025
Eli Lilly and Company, which is listed on the New York Stock Exchange as LLY, has reached a final agreement to buy Adverum Biotechnologies, Inc.,
Eli Lilly and Company, which is listed on the New York Stock Exchange as LLY, has reached a final agreement to buy Adverum Biotechnologies, Inc.,
After World Mental Health Day, the Humana Foundation, which is the charity part of Humana Inc., worked with the Jewish Heritage Fund and the University
NextGen Healthcare, a leading provider of cloud-based healthcare technology, has announced a new partnership with Eyefinity, which is part of VSP Vision, to improve solutions
ClostraBio, a biotech company that makes next-generation probiotics for gut health, shared some big updates. They launched their first product with Designs for Health, started
Abolis Biotechnologies, a company that uses microorganisms for industrial solutions, has joined forces with EUROAPI, a top global producer of active pharmaceutical ingredients, to create
Provation has named Dr. Lukasz Kowalczyk as its Executive Medical Director. Dr. Kowalczyk is a well-known gastroenterologist and a leader in health technology, bringing both
GSK plc announced that the U.S. Food and Drug Administration has approved Blenrep (belantamab mafodotin-blmf) when used along with bortezomib and dexamethasone for adult patients
Pulse Biosciences, Inc., a company that’s leading the way with its nPulse technology based on its own Nanosecond Pulsed Field Ablation (nsPFA) energy, has announced
The CHECK study, a cross-sectional survey of over 10,000 participants, is the first to quantify the prevalence of chronic hand eczema (CHE) in the U.S.
Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
Funding accelerates advancement of AngioAI+, the company’s investigational AI-based platform for diagnosing CAD and CMD. AngioInsight, a leader in AI-powered cardiovascular diagnostics, announced the appointment of Shlomi
– New Three-Year Interim Data Demonstrates Livdelzi May Help Stabilize or Improve Liver Health in PBC Patients – Gilead Sciences, Inc. will present new research that